Changeflow GovPing Pharma & Drug Safety Patent Application for Nucleic Acid Library Pre...
Routine Notice Added Draft

Patent Application for Nucleic Acid Library Preparation

Email

Summary

The USPTO has published a new patent application, US20260085306A1, detailing ligation-free methods for preparing nucleic acid libraries for high-throughput sequencing. The application was filed on January 16, 2024, and published on March 26, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a patent application (US20260085306A1) filed with the USPTO. It describes novel compositions and methods for generating libraries for high-throughput sequencing without the use of ligation. The inventors are listed as Jannine Forst, Morten Rasmussen, and Stephane B. Gourguechon. The application was filed on January 16, 2024.

As this is a patent application publication, it does not impose immediate regulatory obligations or deadlines on regulated entities. However, it signifies potential future developments in biotechnology and sequencing technologies. Companies in the pharmaceutical and biotechnology sectors should monitor this application and related patents for potential intellectual property implications and future technological advancements.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

LIGATION FREE METHODS OF NUCLEIC ACID LIBRARY PREPARATION

Application US20260085306A1 Kind: A1 Mar 26, 2026

Inventors

Jannine FORST, Morten RASMUSSEN, Stephane B. GOURGUECHON

Abstract

Provided herein are compositions and methods for generating libraries for high throughput sequencing without using ligation, and methods of using same.

CPC Classifications

C12N 15/1065 C12N 15/1068

Filing Date

2024-01-16

Application No.

18414259

View original document →

Named provisions

Abstract Filing Date Application No.

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085306A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Research Nucleic Acid Sequencing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Biotechnology Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!